Somatuline for subcutaneous injection 90 mg (YJ code: 2499413G2021, standard: 90mg x 1 tube), manufactured by Teijin Pharma, contains lanreotide acetate. This somatostatin analog treats acromegaly and certain neuroendocrine tumors, with the 90 mg dose often serving as a starting point for acromegaly, given every four weeks.
Somatuline for subcutaneous injection 90 mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →